Related Experiment Videos
Toward Long-Term Visual Field Appearance Forecasting Using Artificial Intelligence for Ophthalmic Education and
Ye Tian1, Puja Bhavsar2, Mingyang Zang1
1Department of Biomedical Engineering, Columbia University, New York, New York.
Ophthalmology Science
|June 8, 2026
Summary
Artificial intelligence (AI) forecasts visual fields (VF) to help train ophthalmology residents in detecting glaucoma progression (GP). AI guidance led to more conservative decisions and higher confidence, aiding in faster glaucoma treatment.
Area of Science:
- Ophthalmology
- Artificial Intelligence
- Medical Imaging
Background:
- Glaucoma progression (GP) detection is crucial for timely treatment.
- Current methods for characterizing GP can be challenging for trainees.
- Visual field (VF) testing is a key diagnostic tool in glaucoma management.
Purpose of the Study:
- To develop and evaluate an AI tool for forecasting visual field (VF) appearance to aid in training ophthalmic residents.
- To assess the clinical utility and impact of AI-generated VF forecasts on resident decision-making.
- To provide state-of-the-art, post hoc-explainable AI forecasts for glaucoma progression detection.
Main Methods:
- Retrospective study utilizing the largest available VF dataset, including minority populations.
- Implementation of GenVF, a generative vision transformer, for forecasting VFs up to 10 years.
- User study involving 8 ophthalmology residents comparing AI-forecasted VFs with actual VFs.
Main Results:
- AI-forecasted VFs (AI-VF) showed uniform mean absolute error (MAE) across resident experience levels, unlike VF-only analysis.
- Residents using AI forecasts made more conservative decisions and reported higher confidence.
- Reaction times for glaucoma progression detection remained comparable with or without AI guidance.
Conclusions:
- The GenVF model provides state-of-the-art, post hoc-explainable AI for glaucoma progression detection.
- AI-assisted VF forecasting enhances resident confidence and decision-making, potentially expediting glaucoma treatment.
- Future research should address variability in AI effectiveness across expertise and patient-specific contexts.